References
- Diaz-Santana MV, O’Brien KM, Park Y-M-M, Sandler DP, Weinberg CR. Persistence of risk for type 2 diabetes after gestational diabetes mellitus. Diabetes Care. 2022;45(4):864–870. doi:10.2337/dc21-1430
- Huang LT, Wu SL, Liao X, Ma SJ, Tan HZ. Adiponectin gene polymorphisms and risk of gestational diabetes mellitus: a meta-analysis. World J Clin Cases. 2019;7(5):572–584. doi:10.12998/wjcc.v7.i5.572
- Tangjittipokin W, Thanatummatis B, Wardati F, Narkdontri T, Teerawattanapong N, Boriboonhirunsarn D. The genetic polymorphisms and levels of adipokines and adipocytokines that influence the risk of developing gestational diabetes mellitus in Thai pregnant women. Gene. 2023;860:147228. doi:10.1016/j.gene.2023.147228
- Cheng JX, Yu K. New discovered adipokines associated with the pathogenesis of obesity and type 2 diabetes. Diabetes Metab Syndr Obes. 2022;15:2381–2389. doi:10.2147/DMSO.S376163
- Hoffmann T, Morcos YAT, Janoschek R, et al. Correlation of metabolic characteristics with maternal, fetal and placental asprosin in human pregnancy. Endocr Connect. 2022;11(3). doi:10.1530/EC-22-0069
- Ott R, Stupin JH, Melchior K, et al. Alterations of adiponectin gene expression and DNA methylation in adipose tissues and blood cells are associated with gestational diabetes and neonatal outcome. Clin Epigenetics. 2018;10(1):131. doi:10.1186/s13148-018-0567-z
- Qiao L, Wattez J-S, Lee S, et al. Adiponectin deficiency impairs maternal metabolic adaptation to pregnancy in mice. Diabetes. 2017;66(5):1126–1135. doi:10.2337/db16-1096